Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SoFi Technologies Inc (SOFI) vs GeneDx Holdings Corp (WGS) Price & Performance

SoFi Technologies IncTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

SoFi Technologies Inc vs GeneDx Holdings Corp — how do they compare? SoFi Technologies Inc trades at $17.94 (market cap $23.22B), while GeneDx Holdings Corp trades at $82.63 (market cap $2.44B). The key difference: SoFi Technologies Inc is far larger — about 9.5× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals.

SOFIWGS
Market Cap
$23.22B$2.44B
Sector
FinancialsTechnology
52-Week High
$32.21$167.51
52-Week Low
$15.15$34.51
Enterprise Value
$2.48B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SoFi Technologies Inc

SOFI stock trades at $18.02, down 0.55% on the day, with a bullish technical signal from moving averages but a neutral reading from oscillators. The company reported strong Q2 2026 results, beating EPS estimates with 40% year-over-year adjusted net revenue growth and record loan originations. Revenue guidance for 2026 was raised to $4.75-$4.85 billion. The stock is trading below the consensus price target of $19.50, with analyst sentiment mixed but leaning positive.

The outlook for SOFI is supported by robust member growth and a diversified revenue stream, though risks include dependence on lending growth and potential interest rate sensitivity. The current valuation at a P/E of 36.69 and P/S of 5.6 reflects high growth expectations. Upside potential exists if execution continues, but investors should weigh the premium valuation against competitive and macroeconomic headwinds.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.

Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About SoFi Technologies Inc

SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.

Read more on SOFI

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS